FDA Inspection
Wyeth Pharmaceutical Division of Wyeth Holdings LLCWyeth Pharmaceutical Division of Wyeth Holdings LLC – FDA Inspection, Nov 18, 2011
Record Details
This FDA Inspection record concerns Wyeth Pharmaceutical Division of Wyeth Holdings LLC, with an inspection on November 18, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- November 18, 2011
- Product Type
- Biologics
View Company Profile
ID · d2def70c-934c-43e2-b20f-8c5d91d8edbb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 758809
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Wyeth Pharmaceutical Division of Wyeth Holdings LLC
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2026 | Not classified | Atlanta District Office | Human Cellular, Tissue, and Gene Therapies |
| October 17, 2024 | Not classified | Atlanta District Office | |
| November 10, 2023 | Not classified | Atlanta District Office | |
| November 18, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 26, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- FDA Inspection 1305396 - 2026-04-23
- FDA Inspection 1252280 - 2024-10-17
- FDA Inspection 1234989 - 2023-11-10
- FDA Inspection 1192736 - 2022-11-18
- FDA Inspection 1121288 - 2019-11-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.